242
Views
1
CrossRef citations to date
0
Altmetric
Articles

Design and evaluation of the crimping of a hooked self-expandable caval valve stent for the treatment of tricuspid regurgitation

, &
Pages 533-546 | Received 08 Jul 2015, Accepted 03 Jan 2019, Published online: 18 Feb 2019

References

  • Amerini A, Hatam N, Malasa M, Pott D, Tewarie L, Isfort P, Goetzenich A, Hildinger M, Autschbach R, Spillner J. 2014. A personalized approach to interventional treatment of tricuspid regurgitation: experiences from an acute animal study. Interact Cardiovasc Thorac Surg. 19(3):414–418.
  • Auricchio F, Conti M, De Beule M, De Santis G, Verhegghe B. 2011. Carotid artery stenting simulation: from patient-specific images to finite element analysis. Med Eng Phys. 33:281–289.
  • Auricchio F, Taylor RL. 1997. Shape-memory alloys: modelling and numerical simulations of the finite-strain superelastic behavior. Comput Meth Appl Mech Eng. 143(1–2):175–194.
  • Auricchio F, Taylor RL, Lubliner J. 1997. Shape-memory alloys: macromodelling and numerical simulations of the superelastic behavior. Comput Meth Appl Mech Eng. 146(3–4):281–312.
  • Azaouzi M, Lebaal N, Makradi A, Belouettar S. 2013. Optimization based simulation of self-expanding Nitinol stent. Mater Des. 50:917–928.
  • Azaouzi M, Makradi A, Belouettar S. 2012. Deployment of a self-expanding stent inside an artery: a finite element analysis. Mater Des. 41:410–420.
  • Borghi A, Murphy O, Bahmanyar R, McLeod C. 2014. Effect of stent radial force on stress pattern after deployment: a finite element study. J Mater Eng Perform. 23(7):2599–2605.
  • Boudjemline Y, Agnoletti G, Bonnet D, Behr L, Borenstein N, Sidi D, Bonhoeffer P. 2005. Steps toward the percutaneous replacement of atrioventricular valves: an experimental study. J Am Coll Cardiol. 46(2):360–365.
  • Bruce CJ, Connolly HM. 2009. Right-sided valve disease deserves a little more respect. Circulation. 119(20):2726–2734.
  • Campelo-Parada F, Lairez O, Carrié D. 2017. Percutaneous treatment of the tricuspid valve disease: new hope for the “forgotten” valve. Rev Esp Cardiol (Engl Ed). 70(10):856–866.
  • Coats L, Bonhoeffer P. 2007. New percutaneous treatments for valve disease. Heart. 93(5):639–644.
  • Corno AF, Zhou J, Tozzi P, von Segesser LK. 2003. Off-bypass implantation of a self-expandable valved stent between inferior vena cava and right atrium. Interact Cardiovasc Thorac Surg. 2(2):166–169.
  • Cribier A. 2016. The development of transcatheter aortic valve replacement (TAVR). Glob Cardiol Sci Pract. 2016.
  • Davidson MJ, Cohn LH. 2009. Surgeons' perspective on percutaneous valve repair. Coron Artery Dis. 20(3):192–198.
  • Dean MR. 1996. Interventional radiology—a practical guide. Cardiovasc Intervent Radiol. 19:449–449.
  • Filsoufi F, Anyanwu AC, Salzberg SP, Frankel T, Cohn LH, Adams DH. 2005. Long-term outcomes of tricuspid valve replacement in the current era. Ann Thorac Surg. 80(3):845–850.
  • U.S. Food and Drug Administration. 2014. Guidance for industry and FDA staff—Nonclinical engineering tests and recommended labeling for intravascular stents and associated delivery systems, 2010. In.
  • Ghriallais RN, Bruzzi M. 2014. Self-expanding stent modelling and radial force accuracy. Comput Meth Biomech Biomed Eng. 17(4):318–333.
  • Grogan J, Leen S, McHugh P. 2012. Comparing coronary stent material performance on a common geometric platform through simulated bench testing. J Mech Behav Biomed Mater. 12:129–138.
  • Hsiao H-M, Chiu Y-H, Lee K-H, Lin C-H. 2012. Computational modeling of effects of intravascular stent design on key mechanical and hemodynamic behavior. Comput Aided Des. 44(8):757–765.
  • Huang L, Pu C, Fisher RK, Mountain DJ, Gao Y, Liaw PK, Zhang W, He W. 2015. A Zr-based bulk metallic glass for future stent applications: materials properties, finite element modeling, and in vitro human vascular cell response. Acta Biomater. 25:356–368.
  • Ismail M, Kabinejadian F, Nguyen YN, Wui ETL, Kim S, Leo HL. 2017. Hemodynamic assessment of extra-cardiac tricuspid valves using particle image velocimetry. Med Eng Phys. 50:1–11
  • Ismail M, Kumar GP, Kabinejadian F, Nguyen YN, Cui F, Tay ELW, Leo HL. 2016. An experimental and computational study on the effect of caval valved stent oversizing. Cardiovasc Eng Tech. 7(3):254–269.
  • Kenny D, Hijazi ZM, Walsh KP. 2011. Transcatheter tricuspid valve replacement with the Edwards SAPIEN valve. Catheter Cardiovasc Interv. 78(2):267–270.
  • Kleinstreuer C, Li Z, Basciano C, Seelecke S, Farber M. 2008. Computational mechanics of Nitinol stent grafts. J Biomech. 41(11):2370–2378.
  • Kuetting M, Pott D, Sedaghat A, Ng YA, Egron S, Rosefort C, Werner N, Sachweh J, Steinseifer U. 2015. Right heart transcatheter valve therapies - a review of prostheses for the pulmonary and tricuspid positions. Expert Rev Med Devices. 12(2):163–174.
  • Kumar GP, Cui F, Danpinid A, Su B, Hon JKF, Leo HL. 2013. Design and finite element-based fatigue prediction of a new self-expandable percutaneous mitral valve stent. Comput Aided Des. 45:1153–1158.
  • Kumar GP, Cui F, Phang HQ, Su B, Leo HL, Hon JKF. 2014. Design considerations and quantitative assessment for the development of percutaneous mitral valve stent. Med Eng Phys. 36:882–888.
  • Laule M. 2015. Caval Sapien valve implants for tricuspid regurgitation. Transcatheter Valve Ther. 2015.
  • Laule M, Stangl V, Sanad W, Lembcke A, Baumann G, Stangl K. 2013. Percutaneous transfemoral management of severe secondary tricuspid regurgitation with Edwards Sapien XT bioprosthesis: first-in-man experience. J Am Coll Cardiol. 61(18):1929–1931.
  • Lauten A, Doenst T, Hamadanchi A, Franz M, Figulla HR. 2014. Percutaneous bicaval valve implantation for transcatheter treatment of tricuspid regurgitation: clinical observations and 12-month follow-up. Circ Cardiovasc Interv. 7268–272.
  • Lauten A, Dreger H, Laule M, Stangl K, Figulla HR. 2017. Caval valve implantation. Interventional Cardiology Clinics. 7(1):57–63.
  • Lauten A, Dreger H, Schofer J, Grube E, Beckhoff F, Jakob P, Sinning J-M, Stangl K, Figulla HR, Laule M. 2018. Caval valve implantation for treatment of severe tricuspid regurgitation. J Am Coll Cardiol. 71(10):1183–1184.
  • Lauten A, Ferrari M, Hekmat K, Pfeifer R, Dannberg G, Ragoschke-Schumm A, Figulla HR. 2011. Heterotopic transcatheter tricuspid valve implantation: first-in-man application of a novel approach to tricuspid regurgitation. Eur Heart J. 32(10):1207–1213.
  • Lauten A, Figulla HR, Willich C, Jung C, Rademacher W, Schubert H, Ferrari M. 2010. Heterotopic valve replacement as an interventional approach to tricuspid regurgitation. J Am Coll Cardiol. 55(5):499–500.
  • Lauten A, Figulla HR, Willich C, Laube A, Rademacher W, Schubert H, Bischoff S, Ferrari M. 2010. Percutaneous caval stent valve implantation: investigation of an interventional approach for treatment of tricuspid regurgitation. Eur Heart J. 31(10):1274–1281.
  • Lauten A, Hamadanchi A, Doenst T, Figulla HR. 2013. Management of tricuspid regurgitation by caval valve implantation. J Am Coll Cardiol. 62(23):2258–2259.
  • Lauten A, Laube A, Schubert H, Bischoff S, Nietzsche S, Horstkötter K, Poudel-Bochmann B, Franz M, Lichtenberg A, Figulla HR, et al. 2015. Transcatheter treatment of tricuspid regurgitation by caval valve implantation-experimental evaluation of decellularized tissue valves in central venous position. Catheter Cardiovasc Interv. 85(1):150–160.
  • Lawrence E, Turner I. 2005. Materials for urinary catheters: a review of their history and development in the UK. Med Eng Phys. 27:443–453.
  • Mulaikal TA, Pospishil L, George I, Bapat VN, Hahn RT. 2018. Surgically assisted transcatheter balloon-expandable valve in inferior vena cava for torrential tricuspid regurgitation. CASE: Cardiovasc Imaging Case Rep. 2(5):174.
  • Muller DWM, Farivar RS, Jansz P, Bae R, Walters D, Clarke A, Grayburn PA, Stoler RC, Dahle G, Rein KA, et al. 2017. Transcatheter mitral valve replacement for patients with symptomatic mitral regurgitation: a global feasibility trial. J Am Coll Cardiol. 69(4):381–391.,
  • Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. 2006. Burden of valvular heart diseases: a population-based study. Lancet. 368(9540):1005–1011.
  • O'neill BP, Wheatley G, Bashir R, Edmundowicz D, O'murchu B, O'neill WW, Patil P, Chen A, Forfia P, Cohen HA. 2016. Study design and rationale of the heterotopic implantation of the Edwards‐Sapien XT transcatheter valve in the inferior VEna cava for the treatment of severe tricuspid regurgitation (HOVER) trial. Cathet Cardiovasc Intervent. 88:287–293.
  • O’Neill B, Wang DD, Pantelic M, Song T, Guerrero M, Greenbaum A, O’Neill WW. 2015. Transcatheter caval valve implantation using multimodality imaging: roles of TEE, CT, and 3D printing. JACC Cardiovasc Imaging. 8:221–225.
  • Pande AK, Meier B, Urban P, Verin V, Moles VP, Chappuis F, Mehan VK. 1992. Coronary angiography with four French catheters. Am J Cardiol. 70(11):1085–1086.
  • Pott D, Malasa M, Urban U, Kütting M, Safi Y, Roggenkamp J, Steinseifer U, Hatam N, Autschbach R, Spillner J, et al. 2012. A novel approach to an anatomical adapted stent design for the percutaneous therapy of tricuspid valve diseases: preliminary experiences from an engineering point of view. ASAIO J. 58(6):568–573.
  • Praveen Kumar G, Jafary‐Zadeh M, Tavakoli R, Cui F. 2016. Feasibility of using bulk metallic glass for self‐expandable stent applications. J Biomed Mater Res B Appl Biomater.105(7):1874–1882.
  • Praveen Kumar G, Jafary Zadeh M, Cui F. 2016. Deployment of a bulk metallic glass based self-expandable stent in a patient-specific descending aorta. ACS Biomaterials Science & Engineering.2, no. 11 (2016): 1951–1958.
  • Rodés-Cabau J, Hahn RT, Latib A, Laule M, Lauten A, Maisano F, Schofer J, Campelo-Parada F, Puri R, Vahanian A. 2016. Transcatheter therapies for treating tricuspid regurgitation. J Am Coll Cardiol. 67(15):1829–1845.
  • Rogers JH, Bolling SF. 2009. The tricuspid valve: current perspective and evolving management of tricuspid regurgitation. Circulation. 119(20):2718–2725.
  • Séguéla P-E, Houyel L, Acar P. 2011. Congenital malformations of the mitral valve. Arch Cardiovasc Dis. 104(8–9):465–479.
  • Sengupta, Partho P., and Jagat Narula. “Keeping off the wrong track on the right side: planning for transcatheter caval valve implantation.” (2015): 232
  • Thériault P, Terriault P, Brailovski V, Gallo R. 2006. Finite element modeling of a progressively expanding shape memory stent. J Biomech. 39(15):2837–2844.
  • Wu W, Qi M, Liu X-P, Yang D-Z, Wang W-Q. 2007. Delivery and release of nitinol stent in carotid artery and their interactions: a finite element analysis. J Biomech. 40(13):3034–3040.
  • Wu W, Wang W-Q, Yang D-Z, Qi M. 2007. Stent expansion in curved vessel and their interactions: a finite element analysis. J Biomech. 40(11):2580–2585.
  • Wu W, Yang D-Z, Qi M, Wang W-Q. 2007. An FEA method to study flexibility of expanded coronary stents. J Mater Process Technol. 184(1–3):447–450.
  • Zhu X, Li Q, Wu Z. 2016. Long-term outcomes of tricuspid valve replacement. Ann Thorac Surg. 102(6):2134.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.